PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

から入手可能:

Arrotex Pharmaceuticals Pty Ltd

INN（国際名）:

pramipexole dihydrochloride monohydrate

医薬品形態:

Tablet, uncoated

構図:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

投与経路:

Oral

パッケージ内のユニット:

10, 30, 100

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

製品概要:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

認証ステータス:

Licence status A

承認日:

2014-09-23